Radiopharmaceuticals News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–4 of 4 articles
Earlier
High impact NewsMay 4, 2026
Accord Healthcare Relaunches Tadalafil Tablets in Multiple Dosage Strengths, Expanding Generic ED Treatment Access
2 min
Dr. Sarah MitchellHigh impact NewsApr 30, 2026
Sprout Pharmaceuticals Addyi (Flibanserin) Maker Named Top 10 Most Influential Health Company by TIME 2026
2 min
Dr. Natalie HughesHigh impact NewsApr 29, 2026
C-Ray Therapeutics Receives FDA Acceptance for Copper-64 Drug Master File, Advancing Radiopharmaceutical Development
FDA · 2 min
Michael RiveraHigh impact NewsApr 28, 2026
Aclaris Therapeutics ATI-052 Phase 1a Trial Results and ATI-2138 Lead Indication Update Set for April 28, 2026
2 min
Dr. Laura BennettExplore intelligence